1953
DOI: 10.1139/cjms53-053
|View full text |Cite
|
Sign up to set email alerts
|

The Antibacterial Spectrum of Ustilagic Acid

Abstract: Ustilagic acid is shown to be relatively inactive against common Gram-positive and Gram-negative pathogenic bacteria and against Mycobacterium tuberculosis. Serum and urine levels in rabbits following oral administration are much lower than the concentration required for in vitro inhibition of most bacteria tested. Human serum depresses the antibacterial effect of ustilagic acid in vitro. The drug had no effect on the course of experimental infection in mice.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
1

Year Published

2008
2008
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
0
3
1
Order By: Relevance
“…With respect to the specificity of flocculosin, it was not surprising to find a rather similar antibacterial spectrum than the one obtained by Haskins and Thorn (1951) with UA, given the close structural analogy between the two molecules. However, our results differed notably from those obtained by Reed and Holder (1953) who stated that 96% of the 300 bacterial species tested required more than 100 μ g ml −1 to be inhibited. This discrepancy is most likely attributable to medium alkalinity since their bioassays were run in nutrient agar that will titre at pH 6·8 if no amendments are made.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…With respect to the specificity of flocculosin, it was not surprising to find a rather similar antibacterial spectrum than the one obtained by Haskins and Thorn (1951) with UA, given the close structural analogy between the two molecules. However, our results differed notably from those obtained by Reed and Holder (1953) who stated that 96% of the 300 bacterial species tested required more than 100 μ g ml −1 to be inhibited. This discrepancy is most likely attributable to medium alkalinity since their bioassays were run in nutrient agar that will titre at pH 6·8 if no amendments are made.…”
Section: Discussioncontrasting
confidence: 99%
“…2005) has also been shown to have antifungal and antibacterial activity and low toxicity on mammals (Haskins and Thorn 1951). When tested in a preliminary clinical trial in unbuffered conditions, UA was reported to be inactive (Reed and Holder 1953). However, we recently demonstrated that pH played a major role on the activity of flocculosin, which is optimal in acidic conditions and almost nil at neutral pH (Mimee et al.…”
Section: Introductionmentioning
confidence: 99%
“…1b). Ustilagic acid displays strong surface activity and was shown to act antagonistically to both prokaryotic and eukaryotic microorganisms (Haskins and Thorn, 1951;Reed and Holder, 1953). Glycolipids identical or similar to ustilagic acid have been identified only in very few fungi, most of which are closely related to U. maydis (Kulakovskaya et al, 2004(Kulakovskaya et al, , 2005Mimee et al, 2005;Puchkov et al, 2002).…”
Section: Biosynthesis Of Extracellular Glycolipidsmentioning
confidence: 98%
“…Culture supernatants of U. maydis (or Ustilago zeae, as it was called at that time) were successfully tested for antibiotic activity at the Northern Regional Research Laboratory in Peoria, Illinois (Haskins, 1950), the same place where in 1943 the famous Penicillium chrysogenum strain was isolated, the first isolate that allowed large-scale production of penicillin. The active principle of U. maydis was named ustilagic acid and was found to be a secreted glycolipid, which is toxic for a variety of prokaryotic and eukaryotic microorganisms (Haskins and Thorn, 1951;Reed and Holder, 1953). Although initial attempts were already started for fermentation of ustilagic acid in large-scale (Roxburgh et al, 1954), further investigations revealed that the potential use of ustilagic acid for medical and therapeutical purposes was limited due to instability of this drug if administered orally.…”
Section: Introductionmentioning
confidence: 99%